CAPRICOR THERAPEUTICS, INC.
CAPR · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Krasney Karen: Form 4
Insider disclosure · Filed · Report period 25 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001133869 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- CAPR on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 10865 Road To The Cure, Suite 150, San Diego, CA, 92121
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Nile Therapeutics, Inc. (to 20 Nov 2013), SMI PRODUCTS INC (to 19 Sep 2007)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields